Viewing Study NCT06033261


Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2026-02-03 @ 7:10 PM
Study NCT ID: NCT06033261
Status: COMPLETED
Last Update Posted: 2025-05-08
First Post: 2023-09-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
Sponsor: ModernaTX, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Genital Herpes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HSV-2 View
None Herpes Simplex Virus Type 2 View
None HSV-2 vaccine View
None Genital Herpes View
None mRNA-1608 View